Navigation Links
Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
Date:11/27/2007

- Excaliard closes $15.5 million Series A financing from Alta Partners,

ProQuest Investments and RiverVest Venture Partners

CARLSBAD, Calif. and ENCINITAS, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Excaliard Pharmaceuticals, Inc. announced today a new collaboration to discover and develop antisense drugs for the local treatment of fibrotic diseases, including scarring. Isis has granted Excaliard an exclusive worldwide license for the development and commercialization of certain antisense drugs. Excaliard made an upfront payment to Isis in the form of equity and paid Isis $1 million cash for the licensing of a particular gene target. In addition, Isis is eligible to receive development milestones and royalties on antisense drugs developed by Excaliard.

"Isis has made superb progress in the development of second-generation antisense drugs over the last few years, as evidenced by its clinical pipeline and current collaborations with companies such as Bristol-Myers Squibb, Eli Lilly and Ortho-McNeil among others. Having access to Isis' antisense technology and expertise provides a great opportunity for Excaliard," said J. Gordon Foulkes, Ph.D., acting CEO for Excaliard and Managing Director of RiverVest Venture Partners, who co-founded Excaliard and provided the initial seed funding for the company.

Excaliard closed a $15.5 million Series A financing, co-led by Alta Partners, ProQuest Investments, and RiverVest Venture Partners, with Farah Champsi, Alain Schreiber and Gordon Foulkes respectively joining the Board of Directors. "It is a pleasure to once again be working with Isis, the leader in the discovery and development of RNA-based therapeu
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
2. MU researchers to collaborate on $20 million project
3. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
4. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
5. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
6. Rosecrance and Chicagos Department of Environment Collaborate to Help Families Dispose of Unwanted Medicines and Drugs
7. CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3.0
8. Free Access to Literature Data on Chagas Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with archive mine and collaborate access to small molecule bioactivity SAR data on parasitic disease
9. SAIC to Collaborate with UK Biometrics Institute
10. General Motors, Virginia Tech scientists collaborate to advance neuroinformatics
11. ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... myEMRchoice.com Enables Personal Health Re... Fort Washington, PA (PRWEB) December 2, 2...sumers is to read their own medical records. With ... control of personal medical records is easier tha...ed healthcare technology company has added service...
(Date:12/2/2009)... Award-winning author James A. Feinstein, M...hort White Coat: Lessons from Patients on Becoming...hird year of medical school--the grueling clinical... (PRWEB) December 2, 2009 -- Most people will, at...ssed in a tiny hospital gown or staring at someone...
(Date:12/2/2009)... Leading medical device software engineerin...ved ISO 13485 certification. A relatively few medi...ave actually achieved ISO 13485 certification. Man...on and adhere to other ISO standards as well. Howe...ware engineering consulting firm to achieve the ri...
(Date:12/2/2009)...IEGO, Dec. 2 Gen-Probe I...1st Annual Piper Jaffray Health Care Conference to... scheduled to be webcast live and may be accessed ...be,s website at www.gen-probe.com . The webcast w...,, About Gen-Probe ,, Gen-Probe Incorpora...
(Date:12/2/2009)...O, Dec. 2 A randomized, controlled...a minimally invasive treatment called percutaneous...ealed that while both treatments help patients in ...ts pain free up to two years later. Results of the...y at the annual meeting of the Radiological Societ...
Breaking Medicine News(10 mins):Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3
...ree condoms for nearly 9 months will soon be provi.../ the New York city logo as a promotional offer. M...uted since June, according to health officials. ...r would materialise in the next couple of months. ...
...cted that by 2020 road accidents will be the third...c health issues like tuberculosis, diarrhoea and H...atalities are expected to increase from 135,000 in...n' released Tuesday. Around 85 percent of th...
...tival, hot air balloon festival for 2 weeks, inaug...as been the joint efforts of Rajasthan Tourism and...ling from 11countries are participating, who will ... hot air balloons, the locale of Rajasthan making ...
...on has been confirmed in Greece, Bulgaria and Sl...ve been initiated by the Italian following detecti... br> The EU confirmed that samples sent to its ...eece. A spokesman said that in keeping with E...
...ll condoms in school through installation of condo... largest political party in Australia.// Ka... Australia's state parliament, said the issue was ...they are certainly telling their friends. We can't...
...riage) is thought to bring an increased number of ...ge lead to betterment in the health of both sexes ...y couples also offer numerous advantages. Prof...alth said that such marriages apart from health be...
Other Medicine News:Health News:Road accidents greater threat than AIDS, TB: WHO 2
(Date:12/2/2009)...FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasd... Drug Administration (FDA) has granted Fast Track ...,s novel, potentially first-in-class, oral anti-ca...nase (PI3K)/Akt pathway, for the treatment of rela... Track program of the FDA is designed to facilitat...
(Date:12/2/2009)...RNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: C...for pathologists, oncologists and the pharmaceutic...icer transition plan that calls for veteran financ...enior Vice President and Chief Financial Officer o...urrent Senior Vice President and Chief Financial O...
(Date:12/1/2009)..., Germany, Dec. 1 Matrox Graphics ...hics solutions, is pleased to announce that FUJIFI...M) Series display controller boards in several of...film Synapse. ,, Fujifilm is one of the leadin...g the world,s first internet-based PACS (SYNAPSE) ...
Breaking Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4FUJIFILM Europe Teams Synapse with Matrox Xenia 2FUJIFILM Europe Teams Synapse with Matrox Xenia 3Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 1Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 2Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 3Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 4Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 5Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 6Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 7Accuray Announces Regionalized Management Strategy for Americas 5647 1Accuray Announces Regionalized Management Strategy for Americas 5647 2Accuray Announces Regionalized Management Strategy for Americas 5647 3Ikaria Receives Award for Excellence by New Jersey Business 26amp 3B Industry Association 5642 1Ikaria Receives Award for Excellence by New Jersey Business 26amp 3B Industry Association 5642 2
... Nov. 20 Duska Therapeutics,Inc., (OTC Bulletin B... its,pivotal Phase 3 ATPace clinical trial protoco...SPA) procedure with the U.S. Food and Drug Adminis...ement with the FDA, Duska intends to initiate a,si...d and randomized Phase 3,clinical trial with its l...
... Clinical data from a prospective,registry presen...hows DVT,treatment with the Trellis(R) Peripheral ... Clara, CA) successfully breaks up the blood clot ... technique, called isolated pharmacomechanical thr...fely than current catheter-directed thrombolysis,(...
Other Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3
CenterPointLock Large Drainable Pouch
CenterPointLock Drainable Mini-Pouch, White
CenterPointLock Cut-to-Fit FlexWear Skin Barrier, Flat
CenterPointLock Cut-to-Fit Flextend Skin Barrier, Convex
Medicine Products: